首页> Otology and neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology> Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: A double-blind, randomized, placebo-controlled phase II study

Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: A double-blind, randomized, placebo-controlled phase II study

导出原文传递

翻译打印收藏纠错

第一作者： Suckfuell,M.

作者： Suckfuell,M. ^[1] ; Lisowska,G. ^[2] ; Domka,W. ^[3] ; Kabacinska,A. ^[4] ; Morawski,K. ^[5] ; Bodlaj,R. ^[6] ; Klimak,P. ^[7] ; Kostrica,R. ^[8] ; Meyer,T. ^[9]

作者单位： Department of ENT, Head and Neck Surgery, Masaryk University, Brno, Czech Republic ^[1] Department of Otolaryngology, Medical University of Warsaw, Warsaw, Poland ^[2] Department of Otolaryngology and ENT Oncology, Pomeranian Medical University, Szczecin, Poland ^[3] Department of ENT, Head and Neck Surgery, Regional Hospital, Kladno, Czech Republic ^[4] Department of Otolaryngology in Zabrze, Medical University of Silesia, Katowice, Poland ^[5] Private ENT Practice, Lichtenfels, Germany ^[6] Department of ENT, Head and Neck Surgery, Martha Maria Hospital, Munich, Germany ^[7] Department of Otolaryngology, District Specialist Hospital, Rzeszow, Poland ^[8] Auris Medical AG, Falknerstrasse 4, 4001 Basel, Switzerland ^[9]

关键词 Acute acoustic trauma Apoptosis Idiopathic sudden sensorineural hearing loss Intratympanic treatment Otoprotection Spontaneous recovery Tinnitus.

发布时间 2014-12-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交